SEC Form 4 · accession 0001225208-16-023962
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P. Phalen
Officer — EVP & President, MedSurg
Period of report
Jan 8, 2016
Accepted (ET)
Jan 11, 2016 · 8:53 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 8, 2016 | S | 18,221 | $17.6744 | D | 88,971 | D | |
| Common StockF3 | holding | — | — | — | 2,429 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.